36 results
Treatment Algorithm for First Time Pulmonary Embolism
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke,
Treatment Algorithm ... for First Time Pulmonary ... #PE #Pulmonary # ... Embolism #Treatment ... #hematology #VTE
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... disease (COPD) ... #COPD #Treatment ... #Algorithm #Management ... SABA #SAMA #ICS #Pharmacology
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... indicate preferred treatment ... #Management #Pulmonary ... #COPD #GOLD2017
The goals of #COPD #treatment include recognizing the impact that both #symptoms and #exacerbations have on
The goals of #COPD ... #treatment include ... for monitoring treatment ... #management #algorithm ... #pharmacology
Causes of Pulmonary Hypertension - Differential Diagnosis Algorithm
Pulmonary Arterial Hypertension
 • Idiopathic
 • Associated with:
Causes of Pulmonary ... Differential Diagnosis Algorithm ... Pulmonary Arterial ... Hypoxemia: • COPD ... Miscellaneous: • Hematologic
Causes of Pediatric Stridor - Differential Diagnosis Algorithm
Present Since Infancy with No Respiratory Distress:
 • Laryngomalacia
Present
Differential Diagnosis Algorithm ... Hemangioma • Vocal Cord ... Differential #Diagnosis #Algorithm ... #Causes #Peds # ... Pediatrics #Pulmonary
Algorithm for Management of Acute Exacerbation of COPD (AECOPD)

Obtain workup for alternate diagnoses and relevant comorbidities:
Algorithm for Management ... Exacerbation of COPD ... #AECOPD #Algorithm ... #Exacerbation #treatment ... #pulmonary
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
management in Pulmonary ... #prescribing #Pulmonary ... PAH #Management #Algorithm ... #treatment #pharmacology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Reduce risk of COPD ... 100 Dosing: 250 mcg ... increase to 500 mcg ... recommendations for the treatment ... #Indications #Pharmacology
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
>10% (or >200 mL ... DLCO >15% (or 3 mL ... Symptomatic treatment ... systemicsclerosis #SSc #pulmonary ... #algorithm